Apeloa Pharmaceutical Co Ltd operates in the Medicinals and botanicals sector.
In addition to historical fundamental analyses, the complete report available to purchase compares Apeloa Pharmaceutical Co Ltd with three other
companies in this sector in China:
Zhejiang Nhu Co Ltd
sales of 6.23 billion Chinese Renmimbi [US$975.93 million]
of which 95%
was Pharmaceutical Chemicals),
Shandong Xinhua Pharmaceutical Company Limited
(4.52 billion Chinese Renmimbi [US$707.79 million]
of which 44%
was Preparations), and
China Resources Double-Crane Pharmaceutical Company Limited
(6.42 billion Chinese Renmimbi [US$1.01 billion]
of which 68%
was Non- transfusion).
Apeloa Pharmaceutical Co Ltd reported sales of 5.55 billion Chinese Renmimbi (US$870.18 million)
December of 2017.
increase of 16.4%
versus 2016, when the company's sales were 4.77 billion Chinese Renmimbi.
Sales at Apeloa Pharmaceutical Co Ltd have increased during each of the previous five years
(and since 2012, sales have increased a total of 60%).
Sales of Other saw an increase
that was more than double the company's growth rate: sales were up
98.7% in 2017, from
12.59 million Chinese Renmimbi to 25.01 million Chinese Renmimbi.